Role of intravenous ascorbic acid in the management of anemia in hemodialysis patients

Conclusions: Intravenous AA as an adjuvant therapy with iron exerts a favorable and significant effect on the Hb, serum ferritin, and CRP levels in patients with ESKD having anemia. The discontinuation of iron therapy only decreases the serum ferritin levels and does not improve the Hb or CRP levels.

Source: Indian Journal of Nephrology - June 19, 2021 Category: Urology & Nephrology Authors: Howayda El Shinnawy Abdel Rahman Khedr Ahmad Alghitany Marina Ramzy Aber Halim Baki Source Type: research